Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRaw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pulmonx (LUNG) Operating Leases (2019 - 2025)

Pulmonx (LUNG) has disclosed Operating Leases for 7 consecutive years, with $18.3 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Leases rose 2.17% to $18.3 million in Q3 2025 year-over-year; TTM through Sep 2025 was $18.3 million, a 2.17% increase, with the full-year FY2024 number at $18.5 million, up 1574.05% from a year prior.
  • Operating Leases was $18.3 million for Q3 2025 at Pulmonx, down from $19.7 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $19.8 million in Q1 2025 to a low of $1.1 million in Q4 2023.
  • A 5-year average of $9.6 million and a median of $7.4 million in 2021 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: plummeted 80.27% in 2023, then surged 1574.05% in 2024.
  • Pulmonx's Operating Leases stood at $6.8 million in 2021, then crashed by 43.76% to $3.8 million in 2022, then tumbled by 71.27% to $1.1 million in 2023, then soared by 1574.05% to $18.5 million in 2024, then dropped by 1.17% to $18.3 million in 2025.
  • Per Business Quant, the three most recent readings for LUNG's Operating Leases are $18.3 million (Q3 2025), $19.7 million (Q2 2025), and $19.8 million (Q1 2025).